chrisvoncsefalvay/vaers-outcomes huggingface dataset:
gotten 5 Pfizer covid vaccines with last dose administered on 20OCT2022/got covid; gotten 5 Pfizer covid vaccines with last dose administered on 20OCT2022/got covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 73-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and on 20Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Mmr vaccine, for Immunisation; Shingles vaccine, for Immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "gotten 5 Pfizer covid vaccines with last dose administered on 20OCT2022/got covid". The event "gotten 5 pfizer covid vaccines with last dose administered on 20oct2022/got covid" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Course: Caller was a 73-year-old female patient who got covid/diagnosed with COVID Monday morning and was prescribed with Paxlovid 300mg/100mg dose pack. She mentioned that she took her first dose at 1:15 PM today. She mentioned that the covid symptoms she had were, no taste buds, still experiencing dizziness, had high fever prior to taking Paxlovid. She added that she contacted her doctor about this but the doctor did not get back to her. Caller mentioned before that she "MMR vaccine" before which she had a reaction, she also had shingles vaccine. She also mentioned at the latter part of the call that she had gotten 5 Pfizer covid vaccines with last dose administered on 20Oct2022. She mentioned that she had a minor reaction, fever, for it. She mentioned that she had gotten a five vaccines of Pfizer COVID 19 vaccine and to the last dose was Oct2022 and she had now COVID and taking Paxlovid.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5, bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300308080 same patient/ product/ different dose (dose 5)/ events;
Burning pain; This case was reported by a other health professional via interactive digital media and described the occurrence of pain burning in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain burning. On an unknown date, the outcome of the pain burning was unknown.   It was unknown if the reporter considered the pain burning to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had burning pain.
Irregular blood pressure over several weeks following booster resulting in visit to ER and 2 nights in hospital.
got shot approx 230PM went home APAP started crying approx 6PM could not be consoled; taken to ER @ 10;
Thursday 21st Oct. Began having red bumps like "bug bites". Some with pimple like appearance . Began on face. Spread daily over extremities and torso. No back or bottom . No fever noted. Bactroban, Hydroxyzine 10/5 Diagnosed: Varicella disease. Also blisters and Crusty.
Dizziness from laying down to sitting up; Shortness of Breath; This is a spontaneous report from a contactable consumer or other non-HCP (patient). This report was not related to a study or program. A 21-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number and Expiration date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 22Apr2021 at 09:30 (at the age of 21-year-old), as DOSE 1, SINGLE for covid-19 immunisation. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. The patient medical history and concomitant medications were not reported. Family Medical History Relevant to AE(s) was none. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Prior Vaccinations (within 4 weeks) was none. AE(s) following prior vaccinations was none. On 23Apr2021 at 09:30, the patient experienced dizziness from laying down to sitting up and shortness of breath. The patient stated that the first dose of Pfizers COVID vaccine yesterday, 22Apr2021, at 9:30. Patient stated today 23Apr2021, he woke up with shortness of breath, stated he did not know if it was from laying a certain way or if it is a side effect of the vaccine. Stated he also wanted to know if he should be taking it more serious or not. The patient was wondering is this a side effect of the vaccine. Patient stated slight dizziness and it is when he goes form laying down to sitting up. The AE(s) did not require a visit to emergency Room and Physician Office. Treatment for the events was none. There was no investigation assessment reported. The patient outcome of the event Dizziness was not resolved, and the outcome of the other event was Unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
injection site. About 3 inches by 5 inch rash.; This case was reported by a consumer via and described the occurrence of injection site rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was unknown.   It was unknown if the reporter considered the injection site rash to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received shingle shot and had a very bad reaction to the Shingles vaccine injection site about 3 inches by 5 inch rash about 3 years ago. The follow up would not be possible as no contact details were available.
Patient had MMR, Act HIB, and Varicella on Aug. 25, 2003.  On Sept. 4, 2003 I notices that her glands in neck and behind ear were swelled up and they still are.  On Sept. 11, 2003 she woke with a fever and threw up only one time, but ran a fever for 48 hours.  Sept. 14 woke with red dots on face, neck and down to legs.
Patient was hospitalized on 01/25 d/t non-productive cough, fever, runny nose, & upper respiratory infection
ONLY HAD ONE DAY OF BEING LETHARGIC FROM THE FIRST SHOT; MILD SNIFFLE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received influenza vaccine (Flu shot) for prophylactic vaccination. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. On an unspecified date, the patient experienced lethargic for 1 day from the first shot (Dose number in series 1). Patient had never contracted Covid 19. Patient worked at an ammo assembly manufacturing plant. Patient's employers did not have any type of shutdown due to Covid. Patient continued to go out in public with social distancing and masks if the business required them. Patient continued short trips on days off. Patient reported, between the two shots, she had only mild sniffle during this entire pandemic (Dose number in series 1).  The patient received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on JAN-2022 for prophylactic vaccination.  Patient did not experience any adverse event after booster vaccination (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from only had one day of being lethargic from the first shot, and the outcome of mild sniffle was not reported. This report was non-serious. This case, from the same reporter is linked to 20220336317.
Area where shot was administered is inflamed and red, with a raised large circle about the size of a can.  In talking to a nurse it appears the shot was not put in the right location. It?s below the top of the arm muscle and was not injected all the way, which means I may not have received the full vaccine.
Shortness of breath started getting severe/ diagnosed with CHF/ unable to breathe when laying back in a chair; This is a spontaneous report from a contactable consumer (patient himself). A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15May2021 (Batch/Lot number was not reported) as 2nd dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 24Apr2021 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunization and experienced intermittent SOB 5 days after. He received the second dose on Saturday, 15May2021. Shortness of breath started getting severe on the following Monday (18May2021), worsened on Tuesday, and went to ED on Wednesday. He was diagnosed with CHF. He has experienced being unable to breathe when laying back in a chair and having to stop 5-6 times during a 1 mile walk due to the shortness of breath. He has been referred to a Cardiologist. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
The pt received DTaP/HIB on 03/20/2002. On the next day the pt developed erythema, edema and warm to touch on the right thigh. Pt afebrile and would not bare weight. On 03/22/2002 pt was diagnosed with arthrus reaction.
This solicited report has been received from a 71 years old female consumer referring to herself. The patient's medical history, concurrent condition and concomitant medication were not reported. The patient was fine before. On an unknown date the patient was vaccinated with PNEUMOVAX (lot#, dose and route were not reported). On unknown dates, the patient experienced general muscular pain/sore, chills and fever which was reported as probable side effects of PNEUMOVAX. The outcome of the events were unknown. Additional information is not expected since no contact details was provided.
Extreme headackes, Loss of mobility and Functions. Returned to Doctors office immediately as allowed.
Emp states she started itching on wrists, arms, chest, stomach and back a few hours after receiving her 2nd Hep B vaccine (Received 1st Hep B vaccine 14 yrs ago, does not remember having a rxn). Seen in ED, prescribed BENADRYL, ATARAX & prednisone.
to hospital with SOB, hypoxia (70% on 2L); confused; febrile; positive for COVID; transferred to ICU; on BiPAP; increasing work of breathing; intubated; worsening renal failure; started on CRRT, 10 minutes after started pt went into shock, tachycardia and hypotension; severe anasarca and volume overload, CRRT stopped; pt not able to tolerated; DNR; pt died shortly after CRRT stopped
pt recvd vax;had titer for RRMV 21apr94;8dec94, pt to clinic w/ lt salivary & parotid glands swollen & tender x 3 days; Lt tm fluid present;
Systemic: Dizziness / Lightheadness-Mild, Systemic: Vomiting-Mild
no actual adverse events occurred at time of administration - patient received covid19 vaccine within 14 days of tdap vaccine
bruise on lt deltoid delayed healing & returned to dark purple in color p/4 days of healing;
2nd dose administered  beyond dosing interval window period; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered  beyond dosing interval window period) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 026B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Dexamethasone), Hypertension, Anxiety, Pancreatic insufficiency, Type II diabetes mellitus and Thyroid nodule.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 21-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered  beyond dosing interval window period). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered  beyond dosing interval window period) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment drugs were reported  Nurse stated that they were investigating and got to know that 9 patients who received Moderna COVID-19 vaccine last year in November and December from Lot # 034C21A expired on 29Oct2021 received expired vaccine. Nurse wanted to know whether or not if this lot # expire date was extended. If not, I am assuming that they would be needed to be revaccinated.   Upon providing the inquiry answer, Nurse stated that they do not have any such information on the 9 patients who received expired vaccine. Nurse stated that they will be informing this to their supervisor. And supervisor will proceed forward to further investigate.   This case was linked to MOD-2022-493791 (Patient Link).
This case was reported by a pharmacist via call center representative and described the occurrence of shortness of breath in a patient who received FLULAVAL QUADRIVALENT 2018-2019 season (batch number Y79A5, expiry date unknown) for prophylaxis. On 19th October 2018, the patient received FLULAVAL QUADRIVALENT2018-2019 season .5 ml. On 19th October 2018, less than a day after receiving FLULAVAL QUADRIVALENT2018-2019 season, the patient experienced shortness of breath, increased blood pressure, hives and headache. On an unknown date, the outcome of the shortness of breath, increased blood pressure, hives and headache were unknown. It was unknown if the reporter considered the shortness of breath, increased blood pressure, hives and headache to be related to FLULAVAL QUADRIVALENT 2018-2019 season. Additional information received as follows: The age at vaccination was not reported. The pharmacist stated that the patient experienced some side effects like shortness of breath, headache, elevated blood pressure and hives. The patient was sent to the emergency room. This is 1 of the 12 linked cases, reported by the same reporter.
The day after my second shot, March 10, I experienced what I felt were normal side effects that a lot of people have experienced.  But starting March 11, I have experienced dizziness, double vision, blurred vision, headaches, eye pain, and nausea. With regards to my eyes, it feels like they are out of sync.   Severity varies on an hour to hour, daily basis.  I have multiple sclerosis but have not had a relapse in almost 11 years. I was concerned about my right eye because my original MS diagnosis was via optic neuritis. I did see an ophthalmologist March 16 but was told there is no new nerve damage or inflammation. I have since been prescribed a steroid pack and I?ve been scheduled for updated MRIs (with and without contrast ) at the end of this month.   I was 100% healthy and lived a normal life before the second shot. The first shot I had zero side effects except for soreness at the  shot site.
Four days after first dose large increase in tinnitus.  Tinnitus subsided prior to second dose. The day of second dose tinnitus appeared within hours and remains.
Swollen hot painful gland (i guess)!left side of neck starting at collar bone area going up. Seems more fluid filled than hard lump.
Nausea, diarrhea, dry mouth, weakness, fatigue, flatulence.
vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (vaccination site pruritus) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (vaccination site pruritus). At the time of the report, VACCINATION SITE PRURITUS (vaccination site pruritus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.
It started with bumps on my scalp and progressed to whelps along my hairline. On 4/19/21 at 10 am the whelps covered my neck and started on my left forearm.  It disappeared at 6pm.  This is when the severe pain/burning in my chest started. It has progressed in severity since with the whelps covering my entire body. I would take 50mg of Benadryl every 4 hours with no results.  The whelps and severe itching and burning would continue.
Ongoing dermatitis/eczema all over body. Ongoing chronic flare-ups since the vaccine. Have seen primary, dermatologist and allergist. Used steroids, creams, ointments for over a year. No one can seem to get it under control.
Immediate headache, heart racing, weakness, chest sensations, palpitations, nausea,  After two weeks of continued symptoms suddenly had Afib with RVR event and went to Er
Information has been received from a nurse practitioner concerning a female patient between the age of 68 and 78 years old who on 10/17/03 at a flu clinic was revaccinated in the arm with a dose of pneumococcal 23v polysaccharide vaccine (lot # 646159/0287N). Concomitant vaccine therapy included a normal adult dose of influenza virus vaccine. Subsequently, within hours of the vaccination, the patient developed redness, swelling and pain at the injection site in the arm where the pneumococcal 23v polysaccharide vaccine had been given. The patient was treated in the emergency room with IV ceftriaxone sodium. The patient was later seen by her own physician and has since recovered. It was also reported that the patient thought that it had been more than 5 years since she was vaccinated, however, it was also reported that in January 2001 she had been vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. No product quality complaint was involved. Upon internal review, redness, swelling and pain at the injection site were determined to be other important medical events (OMIC). It was also reported that three other female patients were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot # 646159/0287N) and also developed redness, swelling and pain at the injection site. Additional information has been requested.
"Covid Arm" started on day 8, following initial injection; symptoms include red rash about 5 inches in length, from top of shoulder to mid-bicep area, slight swelling, and itching.
Information has been received from a healthcare student referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported. In approximately October 2014 (reported as a year ago), the immunocompetent patient was vaccinated with a dose of PNEUMOVAX 23 (dose, route and lot # were not reported). On an unknown date of 2015 (reported a few days ago). the patient inadvertently received a second dose of PNEUMOVAX 23 (dose, lot #, expiration date and route were not reported). No adverse effects were reported. Additional information has been requested.
Fainted about one hour following innoculation. The next day, EXTREME joint pain in neck, shoulder, arms, sciatic nerve. Mild nausea. Runny nose.
Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness at the injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE PAIN (Soreness at the injection site). On 21-Jan-2021, INJECTION SITE PAIN (Soreness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested
Severe muscle pain between shoulder blades--began 1 day after vaccine and 9 days later, he is continuing  to hurt worse for longer periods.
vomiting, dizziness, h/a, fever, BP went up, stomach upset, body ache;this went on the next day till about 5PM;pt states vomited total of 3 times day of vax;
Round circle of redness, pain, heat, swelling  and itchiness expanding over the injection site, eventually measuring greater than 10 cm.  This rash persisted through  day 14, then resolved over the following 3 days.
shoulder injury from influenza vaccine administration-patient was told by provider the vaccine was likely given too high on the shoulder and caused temporary injury that has since resolved
Patient received first dose Pfizer in our immunization room. We talked for 2 minutes then she walked out to our waiting area to be monitored.  Within minutes, she walked up to our drop off counter to tell us she wasn't feeling well but she passed out and fell to the floor.  We lifted her legs and she came to but sat up twice and passed out two more times.  We then kept her laying down with legs elevated until EMS arrived.  EMS checked vitals and she was fine and ended up being picked up by a family member.  No more passing out.  She also reported that she did not eat anything that morning.